Skip to content

Author

K. Dou

We have 7 of 487 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

Type 2 Diabetes Mellitus Modifies the Prognostic Value of LDL Particle Size in Statin‐treated Patients With Coronary Artery Disease: A Large‐scale Cohort Study

LDL‐cholesterol (LDLC) to apolipoprotein B (ApoB) ratio is an accessible and reliable proxy for the LDL‐particle size. The aim of the present study was to investigate whether type 2 diabetes mellitus (T2DM) modulates the prognostic value of LDL‐C/ApoB ratio in statin‐treated patients with coronary artery disease (CAD)....

X. Bian, Ji-Ning He, Chen-Xi Song et al. · 0 citations
Open access Oct 2026

The Triglyceride-Glucose Index Stratifies Cardiovascular Risk After PCI: A Cohort Study Identifying the Highest-Risk Patients.

BACKGROUND The triglyceride-glucose (TyG) index is a surrogate marker of insulin resistance, but its prognostic value across guideline-defined cardiovascular risk strata remains unclear. METHODS In this retrospective cohort study, 23,592 patients undergoing percutaneous coronary intervention (PCI) were stratified int...

Bo-Wen Li, Zhi-Hao Zheng, Ji-Ning He et al. · 0 citations
Sep 2026

Joint association of high-sensitivity C-reactive protein-triglyceride glucose index and coronary artery calcification with adverse outcomes in patients with coronary artery disease: a large-scale cohort study.

In patients with CAD, elevated CTI and MSCAC independently portend adverse outcomes, and their coexistence identifies a particularly high‑risk phenotype, which supports the complementary value of metabolic‑inflammatory and anatomic measures in risk stratification.

Song Wen, Zhan-Yuan Chen, Rui Fu et al. · 0 citations
Open access Sep 2026

Prognostic Value of Composite Biomarkers Integrating Insulin Resistance and Coronary Inflammation for Major Adverse Cardiovascular Events in Post-PCI Patients with Coronary Artery Disease Across Glycemic Status: A Prospective Cohort Study

Background The study aimed to assess the prognostic utility of composite Insulin resistance (IR)- various inflammation biomarkers for predicting poor outcomes in coronary artery disease (CAD) patients stratified by glycemic status. Methods The prospective cohort included 1947 CAD patients undergoing PCI with pre-proced...

Zi-Xiang Ye, Chen-Yu Liu, En-Min Xie et al. · 0 citations
Open access Aug 2026

Intensified lipid-lowering strategies and their effect on atherogenic and metabolic markers in coronary artery disease: a prospective cohort study.

Triple LLT was associated with more comprehensive control of atherogenic lipid markers, with a similar trend for IR markers, and stratified intensification of LLT may support individualized risk-factor management in CAD, although cardiovascular outcome benefits require further validation.

Lei Bao, Zhi-Fan Li, Xiao-Ning Liu et al. · 0 citations
Jul 2026

Associations between prediabetes, type 2 diabetes, and incident arrhythmias: a population-based cohort study and Mendelian randomization analysis.

Findings highlight the differential prognostic utility of ADA and WHO/IEC criteria for arrhythmia risk stratification: the ADA criteria offer broader sensitivity for early detection, whereas the stricter WHO/IEC criteria identify a higher-risk subgroup warranting more intensive management.

Yan-Jun Song, Zhihao Zheng, K. Cui et al. · 0 citations
Jul 2026

Evidence from two large prospective cohorts: variations in remnant cholesterol inflammation index and the risk of cardiometabolic multimorbidity in middle-aged and elderly populations.

By integrating lipid and inflammatory pathways, the RCII was significantly associated with incident CMM and may enhance early risk stratification and may enhance early risk stratification.

Song Wen, Zhonghua Sun, Yanjun Song et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.